[HTML][HTML] Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan
Background Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory
outcomes. However, 8%–28% of patients with PTC show tumor recurrence, which may affect …
outcomes. However, 8%–28% of patients with PTC show tumor recurrence, which may affect …
[HTML][HTML] Molecular and cytogenetic features of NTRK fusions enriched in BRAF and RET double-negative papillary thyroid cancer
S Wu, Y Liu, K Li, Z Liang, X Zeng - The Journal of Molecular Diagnostics, 2023 - Elsevier
Rare NTRK-driven malignant neoplasms can be effectively inhibited by anti-TRK agents.
The discovery of NTRK1/2/3-rich tumors in papillary thyroid cancer (PTC) patients is a …
The discovery of NTRK1/2/3-rich tumors in papillary thyroid cancer (PTC) patients is a …
Natural history, predictive factors of apparent disease (structural or biochemical) and spontaneous excellent response in patients with papillary thyroid carcinoma and …
PW Rosario, GF Mourão - Endocrine, 2022 - Springer
Background: About 20% of patients with papillary thyroid carcinoma (PTC) submitted to total
thyroidectomy followed by radioactive iodine (RAI) exhibit an indeterminate response to …
thyroidectomy followed by radioactive iodine (RAI) exhibit an indeterminate response to …
[HTML][HTML] 术前超声引导下注射纳米炭在PTC 全切除手术中临床应用价值
徐宁， 于波， 樊伟业， 姚佳兴， 杨小艺， 李松埔… - Advances in Clinical …, 2024 - hanspub.org
目的: 探讨术前超声引导下向腺体内注射纳米炭在甲状腺乳头状癌全切除手术中的应用价值.
方法: 收集我院接受甲状腺全切除中央区淋巴结清扫术的80 例甲状腺乳头状癌患者 …
方法: 收集我院接受甲状腺全切除中央区淋巴结清扫术的80 例甲状腺乳头状癌患者 …
Indication for radioactive iodine in patients with papillary thyroid carcinoma without apparent disease after total thyroidectomy but with elevated antithyroglobulin …
F Ramos da Silva, PW Rosario… - Clinical …, 2022 - Wiley Online Library
Objective To evaluate a criterion for the selective indication of radioactive iodine (RAI) based
on the short‐term behaviour of antithyroglobulin antibodies (TgAb) in patients with papillary …
on the short‐term behaviour of antithyroglobulin antibodies (TgAb) in patients with papillary …
Therapeutic Outcomes of Recurrent Well-Differentiated Thyroid Carcinomas
Objective The aim of this study was to evaluate outcomes of the recurrent and non-recurrent
groups including disease-specific mortality of patients with well-differentiated thyroid …
groups including disease-specific mortality of patients with well-differentiated thyroid …
[PDF][PDF] Les carcinomes papillaires de la glande thyroïde: Expérience du service ORL de l'HMA
MO MOUSTAHFID - 1996 - wd.fmpm.uca.ma
Les carcinomes papillaires de la glande thyroïde : Expérience du service ORL de l’HMA
Page 1 Année 2022 Thèse N321 Les carcinomes papillaires de la glande thyroïde …
Page 1 Année 2022 Thèse N321 Les carcinomes papillaires de la glande thyroïde …